These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 16638027

  • 1. Hormone therapy in the WHI era.
    Burger HG.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
    [Abstract] [Full Text] [Related]

  • 2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 3. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, Heward CB, Hecht H, Jaff MR, Harman SM, Women's Health Initiative.
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [Abstract] [Full Text] [Related]

  • 4. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS, Clarkson TB, Notelovitz M.
    Ann Med; 2004 Jun; 36(6):402-13. PubMed ID: 15513292
    [Abstract] [Full Text] [Related]

  • 5. Menopausal hormone therapy: currently no evidence for cardiac protection.
    Wenger NK.
    Pediatr Blood Cancer; 2005 Jun 15; 44(7):625-9. PubMed ID: 15747336
    [Abstract] [Full Text] [Related]

  • 6. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.
    Menopause; 2006 Jun 15; 13(1):125-9. PubMed ID: 16607108
    [Abstract] [Full Text] [Related]

  • 7. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM, Naftolin F, Brinton EA, Judelson DR.
    Ann N Y Acad Sci; 2005 Jun 15; 1052():43-56. PubMed ID: 16024750
    [Abstract] [Full Text] [Related]

  • 8. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V.
    Expert Opin Pharmacother; 2009 Sep 15; 10(13):2041-53. PubMed ID: 19563274
    [Abstract] [Full Text] [Related]

  • 9. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ, Ma J, Stafford RS.
    Menopause; 2007 Sep 15; 14(5):853-8. PubMed ID: 17429334
    [Abstract] [Full Text] [Related]

  • 10. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M, North American Menopause Society (NAMS) Advisory Panel.
    Lakartidningen; 2003 May 15; 100(20):1790-7. PubMed ID: 12806859
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
    Tan O, Harman SM, Naftolin F.
    Bull NYU Hosp Jt Dis; 2009 May 15; 67(2):226-9. PubMed ID: 19583558
    [Abstract] [Full Text] [Related]

  • 13. A clinician's review of the WHI-related literature.
    Speroff L.
    Int J Fertil Womens Med; 2004 May 15; 49(6):252-67. PubMed ID: 15751264
    [Abstract] [Full Text] [Related]

  • 14. [What is the actual lesson from the WHI study upon its completion?].
    Pines A.
    Harefuah; 2004 Oct 15; 143(10):722-3, 766. PubMed ID: 15521348
    [Abstract] [Full Text] [Related]

  • 15. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP.
    Curr Womens Health Rep; 2003 Jun 15; 3(3):181-6. PubMed ID: 12734027
    [Abstract] [Full Text] [Related]

  • 16. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 15; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC.
    Menopause Int; 2009 Jun 15; 15(2):55-7. PubMed ID: 19465669
    [Abstract] [Full Text] [Related]

  • 18. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA, Wee CC.
    J Womens Health (Larchmt); 2005 Jun 15; 14(6):507-14. PubMed ID: 16115005
    [Abstract] [Full Text] [Related]

  • 19. Health risks after cessation of postmenopausal hormone therapy.
    Pines A, Sturdee D, Birkhäuser M, International Menopause Society.
    Climacteric; 2008 Jun 15; 11(3):179-80. PubMed ID: 18568782
    [No Abstract] [Full Text] [Related]

  • 20. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.
    J Endocrinol Invest; 2005 Jun 15; 28(10 Suppl):80-4. PubMed ID: 16550729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.